About Green Park & Golf Ventures
Green Park & Golf Ventures is a venture capital firm founded in 2011. It is primarily based out of Dallas, United States. As of Jun 2025, Green Park & Golf Ventures is an active investor, having invested in 81 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Vellum Health Overall, Green Park & Golf Ventures portfolio has seen 5 IPOs and 13 acquisitions including key companies like Savara Pharma, Lantern Pharma and Salarius Pharma. A lot of funds co-invest with Green Park & Golf Ventures, with names like North Texas Angel Network sharing a substantial percentage of its portfolio. Green Park & Golf Ventures has team of 7 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Green Park & Golf Ventures' List of Top Investments
Green Park & Golf Ventures has a portfolio of 81 companies. Their most notable investments are in MicroTransponder and PuraCath Medical.Their portfolio spans across United States, Germany and United Kingdom. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by Green Park & Golf Ventures:
Provider of a suite primary care platform for providers. The platform allows patients to connect with healthcare experts through video calls/text messaging. Users can seek medical guidance and receive personalized treatment through online consultations with doctors. Also, it provides home-based diagnostic/lab test solutions for patients. It allows customers to know the specific genes responsible for causing disease. Also, it provides services to healthcare providers, organizations, and payers.
Key facts about Recuro Health
- Founded Year: 2021
- Location: Richardson (United States)
- Stage: Series B
- Total Funding till date: $89.3M
- Employee Count: 148 as on Mar 31, 2026
- Investors: Ropart Asset Management Funds, Green Park & Golf Ventures and 8 Others
- Latest Funding Round: Series B, Apr 11, 2023, $*****
- Highlight: Editors' Pick
Developer of therapeutics for rare respiratory diseases. The company’s lead product is molgramostim nebulizer solution, which is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar proteinosis (aPAP).
Key facts about Savara Pharma
- Founded Year: 2008
- Location: Austin (United States)
- Annual Revenue: $2.09M as on Dec 31, 2011
- Stage: Public
- Total Funding till date: $67.8M
- Employee Count: 110 as on Mar 31, 2026
- Investors: Bain Capital Life Sciences, Hercules Capital and 20 Others
- Latest Funding Round: Post IPO, Dec 20, 2019, $*****
- Highlight: Public
3. Mission Bio
Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.
Key facts about Mission Bio
- Founded Year: 2014
- Location: San Francisco (United States)
- Stage: Series C
- Total Funding till date: $120M
- Employee Count: 85 as on Mar 31, 2026
- Investors: Cota Capital, National Cancer Institute and 27 Others
- Latest Funding Round: Series C, Aug 05, 2025, $*****
- Highlight: Editors' Pick
Developer of neuromodulation therapy for neurological conditions. The company uses proprietary technology and product- microtransponder's product is the Vivistim Paired VNS System, for helping stroke survivors regain upper limb motor function after their stroke.
Key facts about MicroTransponder
- Founded Year: 2007
- Location: Dallas (United States)
- Valuation: $*****
- Stage: Series F
- Total Funding till date: $180M
- Employee Count: 215 as on Mar 31, 2026
- Investors: The Vertical Group, Gilde Healthcare and 11 Others
- Latest Funding Round: Series F, Mar 05, 2025, $*****
- Highlight: Editors' Pick
Developing drug and companion diagnostics for multi-drug resistant cancers. Its approach is to biomarker-biased genetic screening to identify and treat patients that would benefit most from our drugs. Its lead candidate is Irovfulven-1, a new class of anti-tumor agents to treat multi-drug-resistant cancers.
Key facts about Lantern Pharma
- Founded Year: 2013
- Location: Dallas (United States)
- Stage: Public
- Total Funding till date: $7.12M
- Employee Count: 28 as on Mar 31, 2026
- Investors: Bios Partners, Green Park & Golf Ventures and 3 Others
- Latest Funding Round: Grant (prize money), Jan 03, 2022, $*****
- Highlight: Public
Green Park & Golf Ventures' Year-on-Year Investment Trends
Green Park & Golf Ventures has invested in 81 companies over the last 14 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 4 investments. Its most recent first time investment was in Vellum Health and most recent follow-on round was in MicroTransponder.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 3 | 1 | 4 |
2024 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
2022 | 3 | 2 | 5 |
2021 | 7 | 0 | 7 |
2020 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2018 | 4 | 2 | 6 |
2017 | 1 | 1 | 2 |
Green Park & Golf Ventures' Investments by Stage
Green Park & Golf Ventures has made 15 investments in Seed stage with an average round size of $1.46M, 11 investments in Series A stage with an average round size of $4.61M, 9 investments in Series B stage with an average round size of $15.9M, 2 investments in Series C stage with an average round size of $3.39M and 1 investment in Conventional Debt stage.Stage of entry | No. of Investments |
|---|---|
Seed | 15 |
Series A | 11 |
Series B | 9 |
Series C | 2 |
Conventional Debt | 1 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' Investments by Sector
Green Park & Golf Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, Consumer and High Tech. Notably, it has invested in 72 Tech companies, 68 Enterprise (B2B) companies, 40 Software companies and at least 16 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 19 |
Enterprise Applications | 15 |
HealthTech | 10 |
Consumer | 6 |
High Tech | 6 |
Others | 30 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' Investments by Geography
Green Park & Golf Ventures has made most investments in United States (36), followed by Germany where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 36 |
Germany | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' recent investments
Green Park & Golf Ventures has not made any investment in 2026 so far.Here are the most recent investments by Green Park & Golf Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 26, 2025 | United States | Series A | 9787 | ||
Apr 22, 2025 | United States | Seed | 5143 | [+2] | |
Mar 05, 2025 | United States | Series F | 3276 | [+6] | |
Feb 03, 2025 | United States | Series A | 5295 | [+4] | |
Feb 27, 2024 | United States | Seed | 8688 |
IPOs and Publicly Listed companies in Green Park & Golf Ventures' Portfolio
5 of Green Park & Golf Ventures' portfolio companies have become public. Lantern Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2020 at marketcap of $93.3M and Atreca got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $455M.Here are Green Park & Golf Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 11, 2020 | Feb 26, 2015 | Seed | 4568 | |
Jun 20, 2019 | - | - | 2661 | |
Jul 27, 2018 | - | - | 3234 | |
Apr 27, 2017 | - | - | 7688 | |
- | - | - | 9575 |
Acquired companies in Green Park & Golf Ventures' Portfolio
13 companies from Green Park & Golf Ventures' portfolio have been acquired. The most recent acquisition was Semler Scientific in Jan 2026 by Strive for $*****.Here are Green Park & Golf Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 16, 2026 | - | - | 3715 | |
Aug 22, 2023 | Nov 30, 2018 | Series A | 2201 | |
Jul 29, 2022 | Mar 24, 2016 | Series B | 2782 | |
Dec 20, 2021 | Jul 2013 | Seed | 1403 | |
Jun 26, 2021 | - | - | 5356 |
Team profile of Green Park & Golf Ventures
Green Park & Golf Ventures has a team of 7 members including 4 Partners and 1 Principal located in United States. Green Park & Golf Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Green Park & Golf Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Dallas | - | ||
Partner | Dallas | - | ||
Partner | Austin | - | - | |
Partner | Dallas | - | ||
Principal | Houston | - |
Co-investors of Green Park & Golf Ventures
Over the past 14 years, 157 investors have co-invested in Green Park & Golf Ventures's portfolio companies. This includes funds and angels.
- Invested before Green Park & Golf Ventures: HHS, Health Wildcatters and 46 others have invested in rounds before Green Park & Golf Ventures. There are 8 companies where HHS has invested before Green Park & Golf Ventures and 4 companies where Health Wildcatters has invested before Green Park & Golf Ventures.
- Top Co-investors of Green Park & Golf Ventures: 63 investors entered a company along with Green Park & Golf Ventures. These include investors like North Texas Angel Network (3 companies).
- Invested after Green Park & Golf Ventures: A total of 46 investors have invested in Green Park & Golf Ventures's portfolio after their investments. Top Investors include Perot Jain (2 companies), NIH (2 companies) and Flippen Group (1 company).
Recent News related to Green Park & Golf Ventures
•
•
•
MicroTransponder receives $65m to advance stroke care with VivistimMedicalDeviceNetwork•Mar 13, 2025•MicroTransponder, Usventure, Exceller Hunt, Green Park & Golf Ventures and 6 others
•
MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke RecoveryPR Newswire•Mar 12, 2025•MicroTransponder, Usventure, USVP, Osage Partners and 7 others
•
Affineon Health Raises $5M for AI-Powered Physician Inbox ManagementHIT Consultant•Feb 05, 2025•Affineon, Green Park & Golf Ventures, Headwater Ventures, Benhamou Global Ventures and 2 others
•
Prolocor Announces $1.7 Million in Bridge FundingNewswire•Feb 27, 2024•Prolocor, Green Park & Golf Ventures, LabCorp
•
Claire England Leads GPG Ventures’ Austin Office Focused on Healthcaresiliconhillsnews.com•Oct 01, 2023•Green Park & Golf Ventures
•
•
Industrial Metaverse Platform Worlds Raises $21M in Series A1 FundingNFTgators•Jan 09, 2023•Worlds, Moneta Ventures, Align Capital Partners, Green Park & Golf Ventures and 5 others
•
Validic Inc. raises $12 million in its latest funding roundPR Newswire•Nov 14, 2022•Validic, Kaiser Permanente Ventures, Arkin Holdings, Green Park & Golf Ventures and 5 others
